Tang Carolyn C. — SEC Form 4 filings
SEC reporting owner CIK 1836662. 7 Form 4 filings on record with FilingPulse; latest filed 2026-06-12.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-01-25 to 2026-06-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 1 filing — 14,468 shares, $318,496 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 10.
- Largest priced transaction: sale of 7,658 shares @ $21.88 ($167,590) in Arcus Biosciences, Inc., filed 2025-12-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Arcus Biosciences, Inc. (RCUS) | General Counsel | 7 | — | 2 legs · 14,468 sh · $318,496 | 10 |
Form 4 filings — Tang Carolyn C.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-12 | 4 | Arcus Biosciences, Inc. (RCUS) | Option exercise (M): 34,090 @ $2.57 · Option exercise (M): 34,090 (derivative) @ $2.57 | EDGAR |
| 2026-01-26 | 4 | Arcus Biosciences, Inc. (RCUS) | Grant/award (A): 24,000 @ $0 · Grant/award (A): 96,000 (derivative) @ $0 | EDGAR |
| 2025-12-18 | 4 | Arcus Biosciences, Inc. (RCUS) | Sale (S): 7,658 @ $21.88 · Sale (S): 6,810 @ $22.16 | EDGAR |
| 2025-01-27 | 4 | Arcus Biosciences, Inc. (RCUS) | Grant/award (A): 37,000 @ $0 · Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2024-12-17 | 4 | Arcus Biosciences, Inc. (RCUS) | Tax withholding (F): 11,339 @ $16.08 | EDGAR |
| 2024-06-18 | 4 | Arcus Biosciences, Inc. (RCUS) | Tax withholding (F): 4,182 @ $16.97 | EDGAR |
| 2024-01-25 | 4 | Arcus Biosciences, Inc. (RCUS) | Grant/award (A): 26,700 @ $0 · Grant/award (A): 108,200 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1836662 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →